Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LOXL2 | Q9Y4K0 | 2/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.40 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.39 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.39 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.39 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.39 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | HRH1 | P35367 | 2/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | NAMPT | P43490 | 1/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.36 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.36 |
| ▸ | NPC1 | O15118 | 1/20 | 0.36 |
| ▸ | RAB9A | P51151 | 1/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3917416 | 0.89 | HRH1 (0.44) | LOXL2ALDH1A1KDM4ECYP1A2CYP3A4 | |
| SCHEMBL167111 | 0.87 | CYP4F2 (0.37) | ALDH1A1KDM4ECYP1A2CYP3A4HIF1A | |
| SCHEMBL3482125 | 0.85 | LOXL2 (0.41) | LOXL2ALDH1A1KDM4ECYP1A2CYP3A4 | |
| SCHEMBL3910843 | 0.82 | LOXL2 (0.42) | LOXL2ALDH1A1KDM4ECYP1A2CYP3A4 | |
| SCHEMBL27094921 | 0.82 | HRH3 (0.39) | ALDH1A1MEN1KMT2AL3MBTL1HRH3 | |
| SCHEMBL107467 | 0.82 | TDP1 (0.43) | LOXL2ALDH1A1TDP1NPC1RAB9A | |
| SCHEMBL3397084 | 0.80 | CYP1A2 (0.43) | ALDH1A1CYP1A2MEN1KMT2AHRH3 | |
| SCHEMBL12458731 | 0.80 | CYP4F2 (0.33) | — | |
| Hydrochloric Acid SCHEMBL18335660 | 0.79 | PABPC1 (0.33) | — | |
| SCHEMBL330048 | 0.79 | LOXL2 (0.46) | LOXL2ALDH1A1KDM4ECYP1A2CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 245 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-120737614-B | Liquid silicone rubber and preparation method thereof | 迈高精细高新材料(宜昌)有限公司 | 2026-05-12 | — | — | CN | claimed |
| EP-4578035-A1 | WET ELECTROLYTIC CAPACITOR CONTAINING A GELLED WORKING ELECTROLYTE | KYOCERA AVX Components Corporation (US) | 2025-07-02 | — | — | EP | claimed |
| CN-120035876-A | Wet electrolytic capacitor comprising gelled working electrolyte | 京瓷AVX元器件公司 | 2025-05-23 | — | — | CN | claimed |
| CN-114467160-B | Solid electrolytic capacitor comprising polyaniline | 京瓷AVX元器件公司 | 2025-04-01 | — | — | CN | claimed |
| CN-114787952-B | Solid electrolytic capacitor comprising a precoat layer and an intrinsically conductive polymer | 京瓷AVX元器件公司 | 2025-02-11 | — | — | CN | claimed |
| CN-114787951-B | Tantalum capacitor with enhanced stability | 京瓷AVX元器件公司 | 2024-11-22 | — | — | CN | claimed |
| EP-4441158-A1 | TUNGSTEN CHEMICAL MECHANICAL POLISHING SLURRIES | Versum Materials US, LLC (US) | 2024-10-09 | — | — | EP | claimed |
| CN-118510855-A | Tungsten chemical mechanical polishing slurry | 弗萨姆材料美国有限责任公司 | 2024-08-16 | — | — | CN | claimed |
| CN-118388318-A | Preparation process of high-purity difluoroethanol | 南通宝凯药业有限公司 | 2024-07-26 | — | — | CN | claimed |
| WO-2024044019-A1 | WET ELECTROLYTIC CAPACITOR CONTAINING A GELLED WORKING ELECTROLYTE | KYOCERA AVX Components Corporation (US) | 2024-02-29 | — | — | WO | claimed |
| US-20160168171-A1 | METHODS OF PRODUCING ORGANOSILICA MATERIALS AND USES THEREOF | EXXONMOBIL RESEARCH AND ENGINEERING COMPANY (US) | 2016-06-16 | — | — | US | claimed |
| US-20160168485-A1 | MEMBRANE FABRICATION METHODS USING ORGANOSILICA MATERIALS AND USES THEREOF | EXXONMOBIL RESEARCH AND ENGINEERING COMPANY (US) | 2016-06-16 | — | — | US | claimed |
| US-20160167032-A1 | AROMATIC HYDROGENATION CATALYSTS AND USES THEREOF | EXXONMOBIL RESEARCH AND ENGINEERING COMPANY (US) | 2016-06-16 | — | — | US | claimed |
| WO-2016094769-A1 | AROMATIC HYDROGENATION CATALYSTS AND USES THEREOF | EXXONMOBIL RESEARCH AND ENGINEERING COMPANY (US) | 2016-06-16 | — | — | WO | claimed |
| US-20160167016-A1 | COATING METHODS USING ORGANOSILICA MATERIALS AND USES THEREOF | EXXONMOBIL RESEARCH AND ENGINEERING COMPANY (US) | 2016-06-16 | — | — | US | claimed |
| WO-2016094774-A2 | METHODS OF PRODUCING ORGANOSILICA MATERIALS AND USES THEREOF | EXXONMOBIL RESEARCH AND ENGINEERING COMPANY (US) | 2016-06-16 | — | — | WO | claimed |
| US-20160168333-A1 | ORGANOSILICA MATERIALS AND USES THEREOF | EXXONMOBIL RESEARCH AND ENGINEERING COMPANY (US) | 2016-06-16 | — | — | US | claimed |
| WO-2016094778-A1 | ORGANOSILICA MATERIALS AND USES THEREOF | EXXONMOBIL RESEARCH AND ENGINEERING COMPANY (US) | 2016-06-16 | — | — | WO | claimed |
| WO-2016094803-A1 | MEMBRANE FABRICATION METHODS USING ORGANOSILICA MATERIALS AND USES THEREOF | EXXONMOBIL RESEARCH AND ENGINEERING COMPANY (US) | 2016-06-16 | — | — | WO | claimed |
| WO-2015122899-A1 | ONE-STEP CONSOLIDATION TREATMENT | HALLIBURTON ENERGY SERVICES, INC. (US) | 2015-08-20 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160168171-A1 | METHODS OF PRODUCING ORGANOSILICA MATERIALS AND USES THEREOF | ZYX, EPB41, OR10J3 | LOXL2 320/4885ALDH1A1 2359/4885KDM4E 1273/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.